Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy.
There is a need to develop innovative therapeutic strategies to counteract epilepsy, a common disabling neurological disorder. Despite the recent advent of additional antiepileptic drugs and respective surgery, the treatment of epilepsy remains a major challenge. The available therapies are largely based on symptoms, and these approaches do not affect the underlying disease processes and are also associated frequently with severe side effects. This is mainly because of the lack of well-defined targets in epilepsy. The discovery that inflammatory mediators significantly contribute to the onset and recurrence of seizures in experimental seizure models, as well as the presence of inflammatory molecules in human epileptogenic tissue, highlights the possibility of targeting specific inflammation related pathways to control seizures that are otherwise resistant to the available AEDs. Emerging studies suggest that miRNAs have a significant role in regulating inflammatory pathways shown to be involved in epilepsy. These miRNAs can possibly be used as novel therapeutic targets in the treatment of epilepsy as well as serve as diagnostic biomarkers of epileptogenesis. This review highlights the immunological features underlying the pathogenesis of epileptic seizures and the possible miRNA mediated approaches for drug resistant epilepsies that modulate the immune-mediated pathogenesis.
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
Arpna
A
Srivastava
Center of Excellence for Epilepsy, A joint NBRC-AIIMS collaboration, NBRC, Manesar, India.
Aparna Banerjee
AB
Dixit
Center of Excellence for Epilepsy, A joint NBRC-AIIMS collaboration, NBRC, Manesar, India.
Jyotirmoy
J
Banerjee
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Manjari
M
Tripathi
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India. Electronic address: saratpchandra3@gmail.com.
P
P
Sarat Chandra
D000818:Animals; D004827:Epilepsy / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D035683:MicroRNAs / Q000378:metabolism*
D035683:MicroRNAs
Cytokines; Epilepsy; Inflammation; MicroRNA